Recently, Matsuda et al. have reported that CYP1A2, another member of the CYP family of enzymes thought to metabolize tobacco-derived carcinogens, is associated with bladder cancer risk in Japanese population [18]. This evidence concerns the gene CYP1A2 and urinary bladder cancer.